Lineage Cell Therapeutics
LCTX
$1.08
Share price
-4.25%
Change (1 day)
-17.40%
Change (1 year)
Categories
Lineage Cell Therapeutics (LCTX) - Net assets
Net assets on the balance sheet as of December 2023 : $62.02 M
According to Lineage Cell Therapeutics
's latest financial reports the company has $62.02 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Lineage Cell Therapeutics - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $62.02 M | -13.78% |
| 2022-12-31 | $71.93 M | -20.86% |
| 2021-12-31 | $90.89 M | -4.45% |
| 2020-12-31 | $95.12 M | -14.49% |
| 2019-12-31 | $0.11 B | 20.6% |
| 2018-12-31 | $92.24 M | -43.84% |
| 2017-12-31 | $0.16 B | 25.86% |
| 2016-12-31 | $0.13 B | 70.72% |
| 2015-12-31 | $76.44 M | 21.88% |
| 2014-12-31 | $62.72 M | 48.41% |
| 2013-12-31 | $42.26 M | 73.96% |
| 2012-12-31 | $24.29 M | -41.4% |
| 2011-12-31 | $41.45 M | -16.12% |
| 2010-12-31 | $49.42 M | 347.41% |
| 2009-12-31 | $11.04 M | -354.14% |
| 2008-12-31 | $-4.35 M | 42.69% |
| 2007-12-31 | $-3.05 M | 63.33% |
| 2006-12-31 | $-1.87 M | 848.83% |
| 2005-12-31 | $-0.2 M | -157.02% |
| 2004-12-31 | $0.34 M | -114.18% |
| 2003-12-31 | $-2.44 M | 107.54% |
| 2002-12-31 | $-1.18 M | 1081.85% |
| 2001-12-31 | $-0.1 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.22 B | 261.30% | 🇺🇸 USA |